Multiplex Genomics
Multiplex Genomics is a Canadian firm focused on developing methods to scale up COVID-19 testing and identify virus variants, leveraging expertise from the Centre for Biodiversity Genomics. They employ advanced molecular methods, automation, and quality assurance to provide high-volume, accurate viral testing services, including PCR-based detection and variant analysis.
Industries
biotechnology
Nr. of Employees
small (1-50)
Services
Pathology testing
Diagnostic pathology testing services.
Microbiology tests
Microbiology testing services for pathogen detection and identification.
Biochemistry tests
Clinical biochemistry testing services.
Histopathology tests
Histopathology testing services for tissue-based diagnostics.
Urine tests
Urinalysis and related urine testing services.
Blood tests
Blood-based testing services for clinical diagnostics.
Pathology testing
Diagnostic pathology testing services.
Microbiology tests
Microbiology testing services for pathogen detection and identification.
Biochemistry tests
Clinical biochemistry testing services.
Histopathology tests
Histopathology testing services for tissue-based diagnostics.
Urine tests
Urinalysis and related urine testing services.
Blood tests
Blood-based testing services for clinical diagnostics.
Expertise Areas
- Genomic surveillance and variant identification
- High-throughput molecular diagnostics
- Molecular assay development and scale-up
- Laboratory automation and workflow optimization
Key Technologies
- Polymerase chain reaction (PCR)
- Targeted sequencing
- Whole-genome sequencing
- Laboratory automation and high-throughput sample handling